Search hospitals

>

Iowa

>

Iowa City

University of Iowa Hospitals and Clinics

Claim this profile

Iowa City, Iowa 52242

Global Leader in Cancer

Global Leader in Breast Cancer

Conducts research for Lung Cancer

Conducts research for Pancreatic Cancer

Conducts research for Stroke

982 reported clinical trials

163 medical researchers

Photo of University of Iowa Hospitals and Clinics in Iowa CityPhoto of University of Iowa Hospitals and Clinics in Iowa CityPhoto of University of Iowa Hospitals and Clinics in Iowa City

Summary

University of Iowa Hospitals and Clinics is a medical facility located in Iowa City, Iowa. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Pancreatic Cancer, Stroke and other specialties. University of Iowa Hospitals and Clinics is involved with conducting 982 clinical trials across 1,797 conditions. There are 163 research doctors associated with this hospital, such as David S. Dickens, Mariko Sato, Muhammad Furqan, and Yousef Zakharia, MD.

Area of expertise

1

Cancer

Global Leader

University of Iowa Hospitals and Clinics has run 84 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
BRAF
2

Breast Cancer

Global Leader

University of Iowa Hospitals and Clinics has run 64 trials for Breast Cancer. Some of their research focus areas include:

Stage IV
HER2 negative
Stage III

Top PIs

Clinical Trials running at University of Iowa Hospitals and Clinics

Non-Hodgkin's Lymphoma

Prostate Cancer

Chronic Obstructive Pulmonary Disease

Lazy Eye

B-Cell Lymphoma

Multiple Myeloma

Carcinoid Tumor

Cancer

Ovarian Cancer

Healthy Subjects

Image of trial facility.

Rondecabtagene Autoleucel

for B-Cell Lymphoma

This Phase 3 study compares rondecabtagene autoleucel (ronde-cel), a dual-targeting CD19/CD20 CAR T-cell therapy, with investigator's choice of CD19 CAR T-cell therapy in patients with relapsed or refractory large B-cell lymphoma in the second-line setting.

Recruiting

2 awards

Phase 3

7 criteria

Image of trial facility.

Biopsy

for Cancer Research

Background: -Patients who are being evaluated and/or treated at the NIH Clinical Center and adult patients at participating sites will be entered onto this tissue procurement protocol for collection of tissue specimens. Objectives: * To obtain samples from adult and pediatric patients for research purposes from tests and procedures that are done as required by the primary research protocol(s) to which a patient is enrolled or as part of their standard-of-care treatment. * To obtain samples for research purposes from non-surgical procedures, such as percutaneous biopsies, performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol. Eligibility: -Adult patients (18 years of age and older) and pediatric patients (younger than 18 years of age) who are being evaluated for and/or treated for cancer at the NIH Clinical Center participating sites. Design: * This is a multicenter tissue procurement protocol with NCI as the coordinating center. * For adult patients: specimens for research purposes, as outlined in this protocol, will be obtained from tests and procedures that are done as required by the primary research protocols to which a patient is enrolled or as part of their standard-of-care treatment. Non-surgical procedures, such as percutaneous biopsies, may also be performed for the sole purpose of obtaining tissue specimens or biological fluids for this protocol. Tissues and biological fluids to be procured may include but are not limited to blood, serum, urine, tumor tissue, normal tissue, pleural fluid, CSF, saliva, bronchial alveolar lavage (BAL), circulating tumor cells, hair follicles, and bone marrow. These specimens will be stored with unique identifiers and used to perform only those research studies that are outlined in this protocol. * For pediatric patients: tumor biopsy/resection tissue used for pediatric preclinical model development will only be from tissue already being obtained as part of a procedure necessary for the patient s clinical care or as part of a primary research protocol; blood specimens will be collected as part of a blood collection already scheduled for the patient s clinical care or as part of the planned pre-procedure bloodwork; volumes collected will not exceed institutional research limits. * Given the risks associated with any invasive procedure, such as tumor biopsy, the procedure will be discussed in detail with the patients and their parents/guardian (as indicated), including the side effects, prior to obtaining a separate consent for each procedure. A separate consent will not be signed prior to obtaining samples by minimally invasive measures, such as venipuncture. * This study has two separate consent forms at the NIH Clinical Center: one for adult patients to donate specimens for ongoing research on assay development and studies of molecular pathways, and one for adult and age-appropriate pediatric patients to donate samples for the generation of preclinical models. The study also has consent form templates for adult and pediatric patients at participating sites to donate specimens to create preclinical models. * Patients may remain on study for the duration of their consent or completion of the planned procedure, whichever comes first.

Recruiting

1 award

N/A

10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Iowa Hospitals and Clinics?

Where is University of Iowa Hospitals and Clinics located?

Who should I call to ask about financial aid or insurance network?

What insurance does University of Iowa Hospitals and Clinics accept?

What awards or recognition has University of Iowa Hospitals and Clinics received?